KR20210093965A - 바이러스의 제조 - Google Patents

바이러스의 제조 Download PDF

Info

Publication number
KR20210093965A
KR20210093965A KR1020217018523A KR20217018523A KR20210093965A KR 20210093965 A KR20210093965 A KR 20210093965A KR 1020217018523 A KR1020217018523 A KR 1020217018523A KR 20217018523 A KR20217018523 A KR 20217018523A KR 20210093965 A KR20210093965 A KR 20210093965A
Authority
KR
South Korea
Prior art keywords
virus
culture
recombinant oncolytic
host cells
bioreactor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020217018523A
Other languages
English (en)
Korean (ko)
Inventor
폴 앤드류 라이트
케이티 왁
밍루이 장
재키 바수르
수잔 니콜 홀리
오거스트 앨런 렌쇼
광위 주
미셸 캐서린 벤델
Original Assignee
웨스턴 온콜리틱스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 웨스턴 온콜리틱스 리미티드 filed Critical 웨스턴 온콜리틱스 리미티드
Publication of KR20210093965A publication Critical patent/KR20210093965A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02Recovery or purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
KR1020217018523A 2018-11-21 2019-11-21 바이러스의 제조 Ceased KR20210093965A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862770577P 2018-11-21 2018-11-21
US62/770,577 2018-11-21
PCT/US2019/062643 WO2020106975A1 (en) 2018-11-21 2019-11-21 Manufacture of virus

Publications (1)

Publication Number Publication Date
KR20210093965A true KR20210093965A (ko) 2021-07-28

Family

ID=70774620

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217018523A Ceased KR20210093965A (ko) 2018-11-21 2019-11-21 바이러스의 제조

Country Status (8)

Country Link
US (1) US20210277363A1 (https=)
EP (1) EP3884044A4 (https=)
JP (1) JP7625519B2 (https=)
KR (1) KR20210093965A (https=)
CN (1) CN113330111A (https=)
AU (1) AU2019384164A1 (https=)
CA (1) CA3120129A1 (https=)
WO (1) WO2020106975A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4222250A1 (en) * 2020-10-02 2023-08-09 Genelux Corporation Bioreactor production of virus from adherent cells
CN121219392A (zh) * 2023-05-31 2025-12-26 康宁股份有限公司 用于提高固定床生物反应器的细胞收集效率的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0981601B1 (en) 1997-01-31 2006-09-06 Schering Corporation Methods for cultivating cells and propagating viruses
EP2287288B1 (en) * 2002-07-09 2012-11-07 Baxter International Inc. Animal protein free media for cultivation of cells
US20070207461A1 (en) * 2004-02-23 2007-09-06 Crucell Holland B.V. Virus Purification Methods
US8541559B2 (en) * 2006-06-12 2013-09-24 Cytos Biotechnology Ag Process for producing aggregated oligonucleotides
EP2615167A1 (en) * 2006-09-15 2013-07-17 MedImmune, LLC Method for eliminating DNA contaminants from viral preparations
JP2010526546A (ja) 2007-05-14 2010-08-05 バヴァリアン・ノルディック・アクティーゼルスカブ ワクシニアウイルス系及び組換えワクシニアウイルス系ワクチンの精製
US8003363B2 (en) * 2007-05-14 2011-08-23 Bavarian Nordic A/S Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
US8785173B2 (en) * 2008-09-24 2014-07-22 Medimmune, Llc Methods for purification of viruses
EP2739293B1 (en) * 2011-08-05 2020-06-10 SillaJen Biotherapeutics, Inc. Methods and compositions for production of vaccina virus
US10851350B1 (en) * 2017-06-27 2020-12-01 Genelux Corporation Bioreactor production of virus from adherent cells

Also Published As

Publication number Publication date
JP7625519B2 (ja) 2025-02-03
CA3120129A1 (en) 2020-05-28
EP3884044A1 (en) 2021-09-29
CN113330111A (zh) 2021-08-31
US20210277363A1 (en) 2021-09-09
JP2022508156A (ja) 2022-01-19
WO2020106975A1 (en) 2020-05-28
AU2019384164A1 (en) 2021-06-03
EP3884044A4 (en) 2022-08-31

Similar Documents

Publication Publication Date Title
KR102749545B1 (ko) 세포 배양물을 가공하는 방법 및 시스템
JP2011524887A5 (https=)
JP6385559B2 (ja) 細胞培養体からのポリオウイルスの精製プロセス
US20250230419A1 (en) Methods of purifying an enveloped virus
US20210277363A1 (en) Manufacture of Virus
CN104027800A (zh) 一种人用狂犬病疫苗的制备方法
KR102245547B1 (ko) 고밀도의 미정제 세포 배양 수거물의 정화를 위한 방법
US9868762B2 (en) Method for purifying virus-like particles (VLP)
US20260085294A1 (en) Process for producing a purified rhabdovirus from cell culture
CN110339351B (zh) 一种兽用狂犬病灭活疫苗的制备方法及该疫苗包含的稳定剂
HK40058237A (en) Manufacture of virus
CN115992101B (zh) 一种流感病毒裂解疫苗原液的制备方法
CN113151197A (zh) 一种Vero细胞培养流感病毒的纯化方法
CN112469821B (zh) 一种制备重组人凝血因子ⅷ的方法
CN113825835B (zh) 使用渗滤方法有效去除杂质
CN114272366B (zh) 一种制备人用乙型脑炎灭活疫苗的方法及疫苗
CN105316296A (zh) 一种纯化腺病毒颗粒的方法
CN117660373A (zh) 一种慢病毒大规模纯化方法及其应用
CN121699879A (zh) 重组脊髓灰质炎病毒制备方法
RU97729U1 (ru) Устройство для получения вирионов хантавирусов из вируссодержащей суспензии
CN120137948A (zh) 一种高效溶菌酶分离提取方法
EA049917B1 (ru) Способ получения очищенного рабдовируса из клеточной культуры
BRPI1014164A2 (pt) processos parra purificar o vírus da raiva e para fabricar uma vacina contra a raiva, bem como vacina contendo vírus da raiva purificado e inativado

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

B15 Application refused following examination

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601